Grayline Research Center Market Research Report
Background
Overview
Founded in 1986, Grayline Research Center is a full-service contract research organization (CRO) specializing in the management and support of Phase II to IV clinical trials under FDA review. Located in Wichita Falls, Texas, the center has established itself as a premier facility in the clinical research industry, offering comprehensive services to pharmaceutical companies.
Mission and Vision
Grayline Research Center is dedicated to advancing medical science by providing high-quality clinical trial management and support. The center aims to meet and exceed the objectives and requirements of the pharmaceutical industry, adhering to the highest standards and processes. Its mission is to contribute to the development of safe and effective medications through rigorous and ethical clinical research.
Primary Area of Focus
The center focuses on conducting Phase II, III, and IV clinical trials, emphasizing subject safety and protocol adherence. It specializes in a wide range of therapeutic areas, including cardiology, family practice, gynecology, neurology, pediatrics, and psychiatry.
Industry Significance
Grayline Research Center plays a crucial role in the clinical research industry by facilitating the development of new medications and treatments. Its commitment to quality and regulatory compliance ensures that clinical trials are conducted ethically and effectively, contributing to the advancement of medical knowledge and patient care.
Key Strategic Focus
Core Objectives
- High-Quality Clinical Trials: Conducting rigorous and ethical clinical trials to support pharmaceutical companies in bringing safe and effective medications to market.
- Subject Safety and Protocol Adherence: Ensuring the safety of participants and strict adherence to study protocols to maintain the integrity of clinical trials.
- Rapid Regulatory Processes: Providing quick turnaround times for regulatory documents, budgets, and contracts, typically within 24 hours, to facilitate efficient study initiation.
Specific Areas of Specialization
Grayline Research Center specializes in a diverse array of therapeutic areas, including:
- Alzheimer’s Disease
- Anxiety Disorders
- Arthritis
- Asthma
- Bipolar Disorder
- Chronic Obstructive Pulmonary Disease (COPD)
- Depression
- Hypertension
- Diabetes
- Geriatric Conditions
- Pain Management
- Parkinson’s Disease
- Peripheral Neuropathy
- Postherpetic Neuralgia (PHN)
- Seasonal Allergies
- Shingles
Key Technologies Utilized
The center employs advanced technologies to enhance the efficiency and accuracy of clinical trials, including:
- Electronic Clinical Outcome Assessments (eCOA): Utilizing digital tools for data collection to improve data accuracy and participant compliance.
- Central Institutional Review Board (IRB) Utilization: Streamlining the approval process for clinical studies to expedite study initiation.
Primary Markets or Conditions Targeted
Grayline Research Center primarily targets pharmaceutical companies seeking to conduct clinical trials in the therapeutic areas mentioned above. Its services are designed to support the development of new treatments and medications for these conditions.
Financials and Funding
Funding History
As a privately held company, Grayline Research Center has not publicly disclosed detailed financial information or funding history. The center operates independently, focusing on providing high-quality clinical trial services to its clients.
Total Funds Raised
Specific details regarding the total funds raised by Grayline Research Center are not publicly available.
Notable Investors
Information about notable investors in Grayline Research Center is not publicly disclosed.
Intended Utilization of Capital
While specific details are not available, it is likely that any capital raised would be utilized to enhance the center's research capabilities, expand its facilities, and invest in advanced technologies to improve the efficiency and quality of clinical trials.
Pipeline Development
Key Pipeline Candidates
Grayline Research Center has been involved in various clinical trials, including studies for treatments targeting major depressive disorder and Alzheimer's disease. For instance, the center participated in a Phase 2 study evaluating the safety and efficacy of forvisirvat (SP-624) for adults with major depressive disorder.
Stages of Clinical Trials or Product Development
The center conducts clinical trials across various phases, including Phase II, III, and IV, supporting the development and approval of new medications.
Target Conditions
Grayline Research Center focuses on a wide range of conditions, such as major depressive disorder, Alzheimer's disease, and other neurological and psychiatric disorders.
Relevant Timelines for Anticipated Milestones
Specific timelines for anticipated milestones in the center's clinical trials are not publicly disclosed.
Technological Platform and Innovation
Proprietary Technologies
Grayline Research Center utilizes proprietary technologies to enhance the efficiency and accuracy of clinical trials, including electronic clinical outcome assessments (eCOA) and central IRB utilization.
Significant Scientific Methods
The center employs rigorous scientific methodologies, including randomized controlled trials, double-blind studies, and placebo-controlled designs, to ensure the reliability and validity of clinical research findings.
AI-Driven Capabilities
While specific AI-driven capabilities are not detailed, the center's use of electronic data collection methods suggests an openness to integrating advanced technologies to improve research processes.
Leadership Team
Key Executive Profiles
- Tonya E. Crosson: President/Director
- Professional Background: Extensive experience in clinical research management.
- Key Contributions: Oversees the strategic direction and operations of the center.
- Dr. Millicent L. McDonald, MD: CEO/Director
- Professional Background: Board-certified physician with a focus on clinical research.
- Key Contributions: Provides medical oversight and ensures the scientific integrity of clinical trials.
- Ms. Kathryn M. Castro: Secretary/Director
- Professional Background: Experience in clinical research coordination and administration.
- Key Contributions: Manages administrative functions and supports regulatory compliance.
- Ms. Cassandra Shinpaugh: Executive Vice President
- Professional Background: Background in clinical research and project management.
- Key Contributions: Leads project teams and ensures the successful execution of clinical trials.
- Mr. Daniel Elbaum: Certified Clinical Research Coordinator
- Professional Background: Certified in clinical research with experience in trial coordination.
- Key Contributions: Coordinates clinical trial activities and ensures protocol adherence.
Leadership Changes
Specific details regarding recent leadership changes or appointments are not publicly disclosed.
Competitor Profile
Market Insights and Dynamics
The clinical research industry is characterized by a growing demand for efficient and reliable clinical trial services. Companies like Grayline Research Center play a pivotal role in supporting pharmaceutical companies to bring new medications to market.
Competitor Analysis
While specific competitors are not detailed, the clinical research sector includes various CROs that offer similar services. Grayline Research Center differentiates itself through its experienced staff, rapid regulatory processes, and commitment to subject safety and protocol adherence.
Strategic Collaborations and Partnerships
Significant Collaborations
Specific details regarding collaborations or partnerships are not publicly disclosed.
Strategic Opportunities and Future Directions
Grayline Research Center has opportunities to expand its services into emerging therapeutic areas, integrate advanced technologies such as artificial intelligence and machine learning to enhance data analysis, and strengthen partnerships with pharmaceutical companies to support the development of innovative treatments.
Contact Information
- Official Website: graylinecdt.com
- Social Media Profiles:
- LinkedIn: Grayline Research Center
Grayline Research Center continues to uphold its mission of advancing medical science through high-quality clinical research, contributing significantly to the development of new and effective treatments.
